Latest filing published 31 Oct 2016 for Histogen Inc., €4,170.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harold Van Wart: trading record in brief
This profile gathers the share dealings of Harold Van Wart across 2 companies, led by CymaBay Therapeutics, Inc. and Histogen Inc. We count 4 filings; the first trade dates from 18 May 2015 and the latest from 27 October 2016.
The open-market record is one-sided, with 3 purchases worth €22k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise.
Half of the purchases are above €290 and half below.
The newest entry dates from 31 October 2016: an option exercise of €4,170, in Histogen Inc. The most recent open-market purchase was published on 19 May 2015, 4,192 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harold Van Wart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,181 shares@ US$0.25100.0% of flowCommon StockSEC:0001209191-16-147474:0
- 7,300 shares@ US$3.34Common StockSEC:0001179110-15-008139:0Canonical exit: 16 Aug 2015 (T+90)
- 100 shares@ US$3.29Common StockSEC:0001179110-15-008139:1Canonical exit: 16 Aug 2015 (T+90)
- 100 shares@ US$3.28Common StockSEC:0001179110-15-008139:2Canonical exit: 16 Aug 2015 (T+90)
4 of 4 declarations
